Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT01604135
PHASE3

Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial

Sponsor: Sahlgrenska University Hospital

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine whether corneal collagen crosslinking is effective in the treatment of progressive keratoconus.

Key Details

Gender

All

Age Range

18 Years - 30 Years

Study Type

INTERVENTIONAL

Enrollment

36

Start Date

2012-05

Completion Date

2025-04

Last Updated

2024-06-06

Healthy Volunteers

No

Conditions

Interventions

DEVICE

Corneal Collagen Crosslinking

Keratoconic corneas that show significant progression as specified in the inclusion criteria section will receive one single treatment with CXL if randomized to the treatment arm. A treatment protocol based on 30 minutes dropping with riboflavin/dextran solution and 10 minutes UV-illumination treatment will be used.

Locations (1)

Department of Ophthalmology, Sahlgrenska University Hospital

Mölndal, Västra Götalandsregionen, Sweden